Search results
Michael Strahan's Daughter Isabella Says She's Suffering From Memory Loss Amid Brain Cancer Battle
ET Online via AOL· 6 hours agoIn the latest post to her YouTube channel, Michael Strahan's 19-year-old daughter revealed a symptom...
How Insitro’s big hires help it push AI drug discovery - San Francisco Business Times
The Business Journals· 5 hours agoThe hires, including former Pfizer Inc. early cancer drug development chief S. Michael Rothenberg as...
Drug companies pay doctors over A$11 million a year for travel and education. Here’s which...
The Conversation· 21 hours agoDrug companies are paying Australian doctors millions of dollars a year to fly to overseas conferences and meetings, give talks to other doctors, and to serve on advisory ...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
CNBC· 10 hours agoBig pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall...
Michael Strahan's Daughter Isabella Reveals Bouts of Memory Loss Amid Cancer Treatment
TooFab· 8 hours agoIsabella Strahan is opening up about a scary side effect of her cancer treatments. Isabella, the...
Cancer drug shows powerful anti-tumor activity in animal models of several different tumor types
Medical Xpress· 2 days agoThe drug has shown powerful anti-tumor activity in animal models of several different tumor types, including ovarian cancer and an aggressive form of breast ...
Isabella Strahan Shares Difficult Cancer Treatment Side Effect
Parade· 3 hours agoThe 19-year-old has undergone three craniotomies and three rounds of chemotherapy since being...
Jefferson spinout Imvax raises $35M to advance brain cancer treatment - Philadelphia Business...
The Business Journals· 9 hours agoImvax, a company spun out of Thomas Jefferson University that is developing a new way to treat brain...
Providence and Ontario Institute for Cancer Research (OICR) partnering to discover and develop mRNA...
WTRF Wheeling· 13 hours agoThis is a unique collaboration that combines OICR's expertise in cancer genomics and translational drug discovery with Providence's next generation of mRNA ...
Ex-finance chief Leung’s firm buys Hong Kong cancer centre as it expands in GBA
South China Morning Post· 4 hours ago“Through this partnership, surgeons, oncologists, and other allied health specialists will create a...